Clinical Trials Browser

Phase 1/2 × Neoplasms, Plasma Cell × belantamab mafodotin × Clear all

NCT04822337 2026-01-20

Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma

Phase 1/2 Recruiting

Multiple Myeloma, Neoplasms, Plasma Cell